NCT03728803

Brief Summary

Nemaline myopathy is a rare congenital myopathy. Respiratory failure is the main cause of death in these patients. The primary objective of this study is to determine the effect of a 8-week inspiratory muscle training program on respiratory muscle function in nemaline myopathy patients. The secondary objective is to determine respiratory muscle function in nemaline myopathy patients and its correlation with clinical severity and general neuromuscular function. The nemaline myopathy patients will be included in the first phase for a clinical characterization. From this phase patients will be selected for the second phase, which is a controlled before-after trial of inspiratory muscle training. The primary outcome is the change in maximal inspiratory pressure (MIP) after active inspiratory muscle training

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 10, 2018

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

October 15, 2018

Completed
18 days until next milestone

First Posted

Study publicly available on registry

November 2, 2018

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 25, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 25, 2021

Completed
Last Updated

December 5, 2024

Status Verified

March 1, 2021

Enrollment Period

2.5 years

First QC Date

October 15, 2018

Last Update Submit

December 2, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change of maximal inspiratory pressure (cmH2O)

    Obtained with handheld device

    Baseline, after 8 weeks sham IMT, after 8 weeks active IMT

Secondary Outcomes (20)

  • Change of diaphragm thickness (mm)

    Baseline, after 8 weeks sham IMT, after 8 weeks active IMT

  • Change of diaphragm thickening (ratio)

    Baseline, after 8 weeks sham IMT, after 8 weeks active IMT

  • Change of diaphragm excursion (cm)

    Baseline, after 8 weeks sham IMT, after 8 weeks active IMT

  • Change of peak cough flow (L/s)

    Baseline, after 8 weeks sham IMT, after 8 weeks active IMT

  • Change of forced vital capacity (% predicted)

    Baseline, after 8 weeks sham IMT, after 8 weeks active IMT

  • +15 more secondary outcomes

Study Arms (2)

Sham inspiratory muscle training

SHAM COMPARATOR

Commercially available threshold IMT trainers (Threshold IMT, Philips Respironics) for inspiration will be used. For sham IMT the valve will be removed, creating a low resistance. The participants will perform the sham IMT twice a day during 15 minutes for a period of 8 weeks.

Device: Threshold IMT, Philips Respironics, Murrysville, PA, USA

Active inspiratory muscle training

ACTIVE COMPARATOR

Commercially available threshold IMT trainers (Threshold IMT, Philips Respironics) for inspiration will be used. After the sham IMT, the participants will perform an active inspiratory muscle training during 8 weeks with the same training schedule. The resistance will gradually be increased in the first couple of weeks until the intended resistance (30% of MIP) is reached.

Device: Threshold IMT, Philips Respironics, Murrysville, PA, USA

Interventions

Active inspiratory muscle training (IMT) by the threshold IMT provides consistent and specific pressure for inspiratory muscle strength and endurance training, regardless of how quickly or slowly patients breathe. This device incorporates a flow-independent one-way valve to ensure consistent resistance and features an adjustable specific pressure setting (in cmH20) to be set. When patients inhale through the Threshold IMT, a spring-loaded valve provides a resistance that exercises respiratory muscles through conditioning.

Active inspiratory muscle trainingSham inspiratory muscle training

Eligibility Criteria

Age6 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • genetically-confirmed nemaline myopathy (mutations in one of the genes causing nemaline myopathy: TPM3, NEB, ACTA1, TPM2, TNNT1, KBTBD13, CFL2, KLHL40, KHLH41, LMOD3, MYPN, RYR1)
  • informed consent from participant or legal representative
  • age-range: between the age of 6-80 years

You may not qualify if:

  • history of another condition that affects respiratory muscle strength or function (e.g. COPD)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Radboud university medical center

Nijmegen, Netherlands

Location

MeSH Terms

Conditions

Myopathies, Nemaline

Condition Hierarchy (Ancestors)

Myopathies, Structural, CongenitalMuscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Baziel van Engelen, Prof. PhD

    Promotor

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SEQUENTIAL
Model Details: A controlled before-after trial of inspiratory muscle training will be performed in patients with nemaline myopathy with respiratory muscle weakness. The 2 sequentially tested conditions are sham IMT and active IMT. Patients are not blinded to the conditions, instead patients are instructed that two training methods are tested. First the effect of breathing technique with low resistance (sham IMT) and secondly with high resistance (active IMT).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 15, 2018

First Posted

November 2, 2018

Study Start

October 10, 2018

Primary Completion

March 25, 2021

Study Completion

March 25, 2021

Last Updated

December 5, 2024

Record last verified: 2021-03

Locations